News Release
2021
-
March 24, 2021
Participation in global Phase III clinical trial for CG0070, a drug for bladder cancer
-
March 1, 2021
Submission of New Drug Application for Avacopan (CCX168), a Complement C5a Receptor Inhibitor, in Japan
-
January 13, 2021
Results of Phase III Clinical Study of AJM300 (Nonproprietary Name: Carotegrast Methyl) for Treatment of Ulcerative Colitis Conducted in Japan (AJM300/CT3 Study) - Primary Endpoint Achieved -
